MindMed is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders. MindMed's mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. The company is developing a pipeline of innovative product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key roles in brain health disorders.